Literature DB >> 9196094

Conventional and modified nasal potential-difference measurement in cystic fibrosis.

T Höfmann1, O Bohmer, G Hüls, H G Terbrack, P Bittner, V Klingmüller, E Heerd, H Lindemann.   

Abstract

Cystic fibrosis (CF) is associated with impaired ion transport across epithelial membranes and an increased transepithelial potential difference (PD) that can be measured in airway epithelium. The aim of this study was to investigate the diagnostic value of nasal PD in CF, and to test a modified approach to the measurement of this PD. The reproducibility and diagnostic sensitivity and specificity of nasal PD measurements were tested with the perfusion technique and with a simplified modification of the technique done with a novel, solid-state exploring electrode. With the perfusion method, basal PD values were different in CF patients (mean +/- SEM: -51.6 +/- 0.9 mV, n = 104) than in normal (-15.5 +/- 0.9 mV, n = 58, p < 0.01) subjects. CF patients with acute rhinitis or other nasal pathology had mean PD values that were intermediate between those of the patients and normal and disease-control groups (-28.3 +/- 1.2 mV, n = 40, p < 0.01, different from normal). The diagnostic sensitivity of the perfusion method for CF was 91.3%, and the specificity was 96.4%. PD measurements with the modified technique correlated highly with the results achieved with the perfusion method (r = 0.94, n +/- 158). The measurement of nasal PD effectively distinguishes CF from control subjects. Care must be taken in the interpretation of measurements made on acutely inflamed epithelium. The modified method was simpler than the conventional perfusion technique, and equally effective.

Entities:  

Mesh:

Year:  1997        PMID: 9196094     DOI: 10.1164/ajrccm.155.6.9196094

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  6 in total

1.  Endogenous nitric oxide in patients with stable COPD: correlates with severity of disease.

Authors:  E Clini; L Bianchi; M Pagani; N Ambrosino
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

2.  Silver/silver chloride electrodes for measurement of potential difference in human bronchi.

Authors:  I Fajac; J Lacronique; A Lockhart; J Dall'Ava-Santucci; D J Dusser
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 3.  Cystic fibrosis: terminology and diagnostic algorithms.

Authors:  K De Boeck; M Wilschanski; C Castellani; C Taylor; H Cuppens; J Dodge; M Sinaasappel
Journal:  Thorax       Date:  2005-12-29       Impact factor: 9.139

4.  Leflunomide prevents alveolar fluid clearance inhibition by respiratory syncytial virus.

Authors:  Ian C Davis; Eduardo R Lazarowski; Judy M Hickman-Davis; James A Fortenberry; Fu-Ping Chen; Xiaodong Zhao; Eric Sorscher; Lee M Graves; Wayne M Sullender; Sadis Matalon
Journal:  Am J Respir Crit Care Med       Date:  2005-12-30       Impact factor: 21.405

5.  In vivo airway surface liquid Cl- analysis with solid-state electrodes.

Authors:  Ray A Caldwell; Barbara R Grubb; Robert Tarran; Richard C Boucher; Michael R Knowles; Pierre M Barker
Journal:  J Gen Physiol       Date:  2002-01       Impact factor: 4.086

6.  How are the ancient cystic fibrosis patients? Cystic fibrosis diagnosed over 60 years-old.

Authors:  C Prados; M Lerín; J J Cabanillas; L Gómez-Carrera; R Álvarez-Sala
Journal:  Respir Med Case Rep       Date:  2017-03-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.